Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Exposure related observations in humans: other data

Administrative data

Endpoint:
exposure-related observations in humans: other data
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: limited documentation; case report

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
Phosphorus trichloride exposure - A follow up study of 27 exposed patients
Author:
Wason S, Gomolin I, Gross P & Lovejoy FH
Year:
1982
Bibliographic source:
Vet. Hum. Toxicol. 24, 17-18
Reference Type:
publication
Title:
Phosphorus trichloride toxicity
Author:
Wason S, Gomolin I, Gross P, Mariam S & Lovejoy FH
Year:
1984
Bibliographic source:
Am. J. Med. 77, 1039-1042

Materials and methods

Type of study / information:
Health effects following accidental exposure
Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Investigation of health effects following accidental exposure
GLP compliance:
no
Remarks:
: not applicable

Test material

Constituent 1
Chemical structure
Reference substance name:
Phosphorus trichloride
EC Number:
231-749-3
EC Name:
Phosphorus trichloride
Cas Number:
7719-12-2
Molecular formula:
Cl3P
IUPAC Name:
phosphorus trichloride
Details on test material:
phosphorus trichloride

Method

Details on study design:
Investigation of health effects following accidental exposure
Exposure assessment:
not specified

Results and discussion

Results:
Patients accidentally were exposed to PCl3 and its degradation products after a railroad accident. Symptoms of exposure included burning eyes (85%; mild conjunctivitis in 36%), shortness of breath (59%), throat irritation (59%) and lacrimation (59%), headache and nausea (48%), burning skin (44%), sputum production (41%), generalized or pleuritic chest pain (33%) and rash/itch (33%), wheezing (26%), blurred vision (22%), vomiting (15%) and abdominal pain (15%). Lactic dehydrogenase was increased in 22% of patients and recovered within four weeks after exposure. Pulmonary function tests showed a decrease of vital capacity in patients within 1/8 mile of the event. Hypoxaemia was recorded in these patients after two months.

Applicant's summary and conclusion

Executive summary:

Patients accidentally were exposed to PCl3 and its degradation products after a railroad accident. Symptoms of exposure included burning eyes (85%; mild conjunctivitis in 36%), shortness of breath (59%), throat irritation (59%) and lacrimation (59%), headache and nausea (48%), burning skin (44%), sputum production (41%), generalized or pleuritic chest pain (33%) and rash/itch (33%), wheezing (26%), blurred vision (22%), vomiting (15%) and abdominal pain (15%). Lactic dehydrogenase was increased in 22% of patients and recovered within four weeks after exposure. Pulmonary function tests showed a decrease of vital capacity in patients within 1/8 mile of the event. Hypoxaemia was recorded in these patients after two months.